All news

Doctors back Moderna, Merck cancer vaccine data

CNBC · RSS · · AI-summarised by FinFlash

Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful outcome for melanoma patients who underwent surgery, even as Wall Street's reaction was muted. The physicians' endorsement contrasts with the market's cooler reception to the data. For investors, the specialist support suggests the clinical case may outlast the initial share price response.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.